New Key Statistics Module, Z-Score and F-Score
OTCPK:IPDQF Key Ratios
| Market Cap $ M | 73.96 |
| Enterprise Value $ M | 49.96 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.71 |
| Price/Sales | 11.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -0.006 |
| Beneish M-Score | -2.5 |
| 10-y EBITDA Growth Rate % | 14.20 |
| 5-y EBITDA Growth Rate % | 36.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.14 |
| EV-to-EBITDA | -3.51 |
| PEG | -- |
| Shares Outstanding M | 2,023.09 |
| Net Margin (%) | -187.80 |
| Operating Margin % | -229.41 |
| Pre-tax Margin (%) | -187.53 |
| Quick Ratio | 6.85 |
| Current Ratio | 7.00 |
| ROA % (ttm) | -33.19 |
| ROE % (ttm) | -38.19 |
| ROIC % (ttm) | -118.30 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.99 |
IPDQF Number of Guru Trades
IPDQF Volume of Guru Trades
Gurus Latest Trades with OTCPK:IPDQF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IPDQF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Impedimed Ltd Insider Transactions
No Available Data
News about OTCPK:IPDQF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers